subscribeSubscribe
Enforcement Report - Week of February 28, 2024

Enforcement Report - Week of February 28, 2024
FDA
28 Feb 2024
Share Share
Assertio Provides Educational Grant for New LGS Foundation Treatments Kits

Assertio Provides Educational Grant for New LGS Foundation Treatments Kits
GLOBENEWSWIRE
24 Apr 2023
Share Share
Aquestive offloads film formulation seizure drug to Assertio

Aquestive offloads film formulation seizure drug to Assertio
Nick Paul Taylor FIERCEPHARMA
31 Oct 2022
Share Share
Aquestive Therapeutics Licenses Sympazan Oral Film to Assertio Holdings, Inc.

Aquestive Therapeutics Licenses Sympazan Oral Film to Assertio Holdings, Inc.
GLOBENEWSWIRE
27 Oct 2022
Share Share
Accord`s Generic Clobazam Receives Approval in the U.S.

Accord`s Generic Clobazam Receives Approval in the U.S.
FDA
06 Sep 2022
Share Share
Aurobindo Pharma ’s Generics Clobazam Receives Approvals In US

Aurobindo Pharma ’s Generics Clobazam Receives Approvals In US
FDA
24 Mar 2022
Share Share
Enforcement Report - Week of January 26, 2022

Enforcement Report - Week of January 26, 2022
FDA
26 Jan 2022
Share Share
IPC`s safety alerts: Clobazam, Baclofen, nitrosamine Rosuvastatin, Ticagrelor

IPC`s safety alerts: Clobazam, Baclofen, nitrosamine Rosuvastatin, Ticagrelor
Laxmi Yadav PHARMABIZ
20 Jul 2021
Share Share
Alkem Labs`s Generic Lacosamide Receives Approval In US

Alkem Labs`s Generic Lacosamide Receives Approval In US
FDA
12 May 2021
Share Share
Slammed by FDA rejection, Aquestive vows to refile by end of year

Slammed by FDA rejection, Aquestive vows to refile by end of year
Amber Tong ENDPTS
29 Sep 2020
Share Share